Immunethep

SME

Immunethep

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem. Sign in

Immunethep

Address

Cantanhede, Centro, Portugal

Contact

info@immunethep.com

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem.

Matchmaking

Connect with Immunethep

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

Immunethep last news

15/11/2023

Fundo do Conselho Europeu de Inovacão investe mil milhões de euros em 'deep tech'

[...] Financiado pelo Horizonte Europa e lançado há cerca de um ano, este fundo do EIC aprovou este valor desde setembro de 2022 e escolheu 159 startups e PME. Dessas, cerca de 70 encontraram co-investidores para avançar no processo de financiamento. A Comissã [...]

31/10/2023

37,4 milhões de euros vão acelerar I&D de três empresas portuguesas com novos produtos para lancar - Ciência - SAPO Tek

[...] As empresas portuguesas conseguiram garantir um apoio de 37,4 milhões de euros na última chamada do European Innovation Council, um instrumento de financiamento do programa Horizonte Europa, onde Portugal tem conseguido manter uma performance que se destaca. Portuga [...]

19/10/2022

Immunethep receives European Innovation Council funding for clinical trials

Immunethep, a Portuguese biotech startup, has been selected by the European Innovation Council (EIC) to receive funding from its EIC Accelerator program.  Immunethep will receive initially a €2.5 million ($2.5 million) grant and is eligible for additional equity investment from the EIC Fund for a project with a total investment of €17.5 million ($17.1 million). The funding aims to advance its paragon novel vaccine (PNV) to first-in-human clinical trials to assess safety, immunogenicity, and early efficacy.  A 2019 study published by The Lancet estimates that 4.95 million people worldwide died from illnesses in which antimicrobial resistance (AMR) played a part. Of those, 1.27 million deaths were the direct result of AMR. If no significant changes occur in the way new drugs are developed to address this, in 2050 AMR will be the largest cause of death in the world, surpassing cancer. Immunethep is one of the 75 startups selected in this EIC Accelerator cut-off among more than 1,000 applications from all over Europe. The 75 selected companies will together receive close to €400 million of funding in a combination of grants and equity investments. The post Immunethep receives European Innovation Council funding for clinical trials appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site's author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.